Clearside opens enrolment in Phase IIb trial of wet AMD therapy

US-based biopharmaceutical company Clearside Biomedical has begun enrolling patients in its Phase IIb trial of CLS-AX (axitinib injectable suspension). The multi-centre …

Hookipa debuts Phase I/II data

Hookipa Pharma  has reported preliminary positive data and trial updates from its ongoing phase II study of HB-200 in combination …

NeuroMetrix encouraged by Phase II Quell data

NeuroMetrix is gearing up to present partial trial results on Quell, the company’s wireless transcutaneous electric nerve stimulation (TENS) device, …

Adiso completes Phase Ib MAD study of UC therapy

Adiso Therapeutics has completed a Phase Ib multiple ascending dose (MAD) trial of ADS051 (BT051) for the treatment of moderate-to-severe …

Nacuity achieves target enrolment in RP therapy trial

Nacuity Pharmaceuticals has achieved its target enrolment of 48 patients in the SLO-RP Phase I/II clinical trial of NPI-001 tablets …